类固醇难治性急性移植物抗宿主病(SR aGVHD)的临床试验
总计1054个结果
-
Mallinckrodt完全的
-
Ohio State University Comprehensive Cancer Center完全的
-
Astellas Pharma Inc完全的骨髓移植 | 移植物抗宿主病 | 移植物抗宿主病 | 移植物抗宿主病日本
-
Astellas Pharma Inc完全的
-
Radboud University Medical Center完全的同种异体干细胞移植 | 急性髓性白血病 | 骨髓增生异常综合症 | 急性移植物抗宿主病 II-IV 级荷兰, 比利时
-
Pharmacyclics LLC.Janssen Research & Development, LLC完全的慢性移植物抗宿主病美国, 澳大利亚, 奥地利, 加拿大, 中国, 克罗地亚, 法国, 德国, 匈牙利, 意大利, 日本, 大韩民国, 新加坡, 西班牙, 台湾
-
Gruppo Italiano Trapianto di Midollo Osseo完全的
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的
-
Stanford University完全的
-
Children's Oncology GroupNational Cancer Institute (NCI)完全的
-
Cancer Institute and Hospital, Chinese Academy...307 Hospital of PLA; Chinese PLA General Hospital; Zhejiang University; Peking Union Medical College未知
-
Fred Hutchinson Cancer CenterNational Heart, Lung, and Blood Institute (NHLBI)尚未招聘
-
MallinckrodtParexel完全的
-
Ann & Robert H Lurie Children's Hospital of ChicagoDana-Farber Cancer Institute; Fred Hutchinson Cancer Center; University of Minnesota完全的
-
Stanford University完全的
-
Guangdong Provincial People's HospitalSun Yat-sen University未知
-
University Health Network, TorontoHoffmann-La Roche终止
-
Janssen Pharmaceutical K.K.完全的
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的
-
Indiana UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)完全的
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's Hospital完全的
-
Mehrdad Abedi, MDMillennium Pharmaceuticals, Inc.完全的
-
Gilead Sciences终止
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)终止